Shanghai Zhangjiang Biotechnology Limited Company
3 clinical trials · Sponsor
◉ Watch Shanghai Zhangjiang Biotechnology Limited Company
| Record | Firm | Date |
|---|---|---|
| Phase II Clinical Trial of Alemtuzumab to Treat B-cell Chronic Lymphocytic Leukemia (NCT01982175) | Shanghai Zhangjiang Biotechnology Limited Company | 2011-07-01 |
| Safety and Efficacy Study of Omalizumab to Treat Allergic Asthma (NCT01976208) | Shanghai Zhangjiang Biotechnology Limited Company | 2010-12-01 |
| Study of CMAB009 to Treat KRAS Wild Type Metastatic Colorectal Cancer (NCT01550055) | Shanghai Zhangjiang Biotechnology Limited Company | 2009-05-31 |
Track Shanghai Zhangjiang Biotechnology Limited Company automatically
Every clearance here is in the API, with alerts when new ones post.